The CNBX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CNBX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CNBX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CNBX Detailed Price Forecast - CNN Money||View CNBX Detailed Summary - Google Finance|
|View CNBX Detailed Summary - Yahoo! Finance||View CNBX Stock Research & Analysis - Zacks.com|
|View CNBX Trends & Analysis - Trade-Ideas||View CNBX Major Holders - Barrons|
|View CNBX Call Transcripts - NASDAQ||View CNBX Breaking News & Analysis - Seeking Alpha|
|View CNBX Annual Report - CompanySpotlight.com||View CNBX OTC Short Report - OTCShortReport.com|
|View CNBX Fundamentals - TradeKing||View CNBX SEC Filings - Bar Chart|
|View Historical Prices for CNBX - The WSJ||View Performance/Total Return for CNBX - Morningstar|
|View the Analyst Estimates for CNBX - MarketWatch||View the Earnings History for CNBX - CNBC|
|View the CNBX Earnings - StockMarketWatch||View CNBX Buy or Sell Recommendations - MacroAxis|
|View the CNBX Bullish Patterns - American Bulls||View CNBX Short Pain Metrics - ShortPainBot.com|
|View CNBX Stock Mentions - StockTwits||View CNBX Stock Mentions - PennyStockTweets|
|View CNBX Stock Mentions - Twitter||View CNBX Investment Forum News - Investor Hub|
|View CNBX Stock Mentions - Yahoo! Message Board||View CNBX Stock Mentions - Seeking Alpha|
|View Insider Transactions for CNBX - SECform4.com||View Insider Transactions for CNBX - Insider Cow|
|View CNBX Major Holdings Summary - CNBC||View Insider Disclosure for CNBX - OTC Markets|
|View Insider Transactions for CNBX - Yahoo! Finance||View Institutional Holdings for CNBX - NASDAQ|
|View CNBX Stock Insight & Charts - FinViz.com||View CNBX Investment Charts - StockCharts.com|
|View CNBX Stock Overview & Charts - BarChart||View CNBX User Generated Charts - Trading View|
Cannabics Pharmaceuticals Study Shows Complex Combinatorial Anti-tumor Activity of Cannabinoids
Posted on Wednesday March 25, 2020
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that its R&D; team in Israel studies the combinatorial effects of purified cannabinoids and has recently revealed complex relations between cannabinoid compounds, some of which bare synergistic effects and some antagonistic effects on the viability of gastrointestinal cancer cells.
Cannabics Pharmaceuticals Offers Its High Throughput Screening (HTS) Platform to the Israeli Health Authorities for SARS-CoV-2 Research
Posted on Wednesday March 18, 2020
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it is offering its High Throughput Screening (HTS) facility, in order to assist with the Israeli national effort in researching and containing SARS-CoV-2.
Cannabics Pharmaceuticals Shows Specific Cultivars Identified to Have Positive Anti-Tumor Effects on Gastric Adenocarcinoma
Posted on Wednesday March 11, 2020
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has completed a scan of selected RCKMC's cannabis strains. Results obtained have shown that two specific strains have demonstrated higher anti-tumor activity.
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, released an update today regarding its pre-clinical studies held at the company's High Throughput Screening (HTS) facility in Israel.